Using Danish registries, researchers identified 22,841 pregnant
women with migraine and compared them with 228,324 pregnant women
without migraine. They found that the debilitating disorder was tied
to pregnancy-associated blood pressure problems as well as
miscarriage.
And newborns of mothers with migraine had higher rates of low birth
weight, respiratory distress syndrome, and febrile seizures compared
with children of mothers without migraine.
Previous smaller studies have seen some of the same outcomes,
including pregnancy-associated hypertension and low birth weight,
coauthor Nils Skajaa from Aarhus University told Reuters Health by
email. But the findings concerning the other neonatal and
neurological risks are new, he said.
Migraine is more common in younger women, with up to 25 percent of
women of reproductive age affected by the disease, the authors wrote
in the journal Headache.
Most earlier studies had fewer than 1,000 migraine patients, they
note.
This new, larger study solidifies what is already known about the
impact of migraine in pregnant women, said Dr. Tina Nguyen, and
obstetrician at UCLA Health in Los Angeles who was not involved in
the study.
Using data from the Danish National Patient Registry and Danish
Medical Birth Registry, Skajaa and colleagues evaluated pregnancies
that occurred from 2005 through 2012.
Nearly 8 percent of women with migraine had pregnancy-associated
hypertension disorders and 11.3 percent of suffered miscarriages,
whereas those rates were 5 percent and 10.3 percent, respectively,
in women without migraine, the study found.
[to top of second column] |
Among the babies these women delivered, 6.1 percent had low birth
weight, compared to 5.1 percent of babies born to mothers with
migraine. And 25.4 percent of pregnancies with migraine had cesarean
deliveries, compared to 22.3 percent of pregnancies without
migraine.
After accounting for other factors that could affect the outcomes,
women with migraine had a 50 percent higher risk for
pregnancy-associated hypertension and a 10 percent higher risk for
miscarriage, while their babies had a 14 percent higher risk for low
birth weight and a 20 percent higher risk for cesarean delivery.
Women taking medications for migraine did not have higher risks of
adverse outcomes compared to women with untreated migraine, the
authors wrote, suggesting that migraine, rather than its treatment,
is tied to adverse outcomes.
Retrospective studies like this one cannot prove cause and effect,
so it's not clear that migraine was the cause of the complications.
Another limitation of the study, which was funded by U.S. pharma
company Amgen, is that women could have been misclassified as not
having migraine if the headaches were diagnosed outside of a
hospital or if they treated themselves with over-the-counter
medications. Furthermore, Nguyen pointed out, the study lacked
details on race as well as socioeconomic status of the participants.
The American Academy of Family Physicians says pregnant women with
new-onset headaches or a new type of headache should be seen by a
doctor.
SOURCE: http://bit.ly/2Xr8HJB Headache, online May 8, 2019.
[© 2019 Thomson Reuters. All rights
reserved.] Copyright 2019 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|